November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
Biomarkers are critical to enabling precision medicine for patients. However, multiple challenges exist, including patient/sample heterogeneity, integration of multiple omics data types and clinical translation. This session will discuss these aspects of biomarker detection and the considerations for successful translation to the clinic.
Anupama Reddy, Ph.D. (Vindhya Data Science)
NR Nirmala, M.Sc., Ph.D. (Vindhya Data Science)
Michael Seiler, Ph.D. (Remix Therapeutics)
Rens Janssens, M.S. (Novartis Oncology)